PTC’s Sephience Launch Appears Off To A Strong Start

 
• By Joseph Haas
  
PTC thinks Sephience is headed for blockbuster sales with solid five-month launch revenue (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business